Scott M. Schuetze

Also affiliated with Michigan Center for Translational Pathology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)”.

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2182

N/A

3.8DataRank · unranked

125 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0.542DataRank · unranked

36 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0.477DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease

medRxiv(2023)10.1101/2023.09.22.23294942

N/A

0DataRank · unranked

0 citations

Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, Scott M. Schuetze, David Shultz, Benjamin Haibe‐Kains +1 more

Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease

Computerized Medical Imaging and Graphics(2024)10.1016/j.compmedimag.2024.102413

N/A

0DataRank · unranked

3 citations

Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, Scott M. Schuetze, David Shultz, Benjamin Haibe‐Kains +1 more

Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysis

Expert Review of Anticancer Therapy(2025)10.1080/14737140.2025.2545551

N/A

0DataRank · unranked

1 citations

Rodney Dixon Dorand, Sean Cohen, Vicki L. Keedy, Scott C. Borinstein, Scott M. Schuetze +3 more

Thematic Analysis of Clinician Documentation Surrounding Treatment Discussions and Decision‐Making in Patients With Desmoid Tumors

Cancer Medicine(2025)10.1002/cam4.71183

N/A

0DataRank · unranked

1 citations

Tianyi Wang, Scott M. Schuetze, Nina Francis‐Levin, Rashmi Chugh, Victoria Wytiaz

Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1073

N/A

0DataRank · unranked

32 citations

Megan Othus, Sandip Pravin Patel, Young Kwang Chae, Kathy D. Miller, Rashmi Chugh +8 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications

The Oncologist(2022)10.1093/oncolo/oyac066

N/A

0DataRank · unranked

20 citations

Lili Zhao, Scott M. Schuetze, Rashmi Chugh, Cindy Jiang

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

(2023)10.1158/1078-0432.c.6530837

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more